Glaukos Corp. (GKOS)
NYSE
Closed
Oct 7, 2026
Day's Range
159.5952 wk Range
73.16Overview - GKOS - Glaukos Corp.
Key Statistics
Valuation
Enterprise Value
9.34B
P/E (Trailing)
‪-49.19‬
P/E (Forward)
‪296.47‬
PEG Ratio
‪5.57‬
Price / Sales (TTM)
‪14.93‬
Price / Book
‪13.38‬
EV / EBITDA
‪-252.48‬
Profitability
Gross Margin
‪81.67%‬
Profit Margin
‪-30.68%‬
Operating Margin
‪-8.49%‬
Return on Assets
‪-5.17%‬
Return on Equity
‪-25.98%‬
Ownership
Shares Outstanding
58.85M
Float
56.82M
Short % of Shares Outstanding
‪8.55%‬
Held by Insiders
‪3.57%‬
Held by Institutions
‪105.30%‬
Price stats
Beta
‪0.69‬
50-Day Avg
‪172.81‬
200-Day Avg
‪135.82‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
14 analysts
Average price target
‪$ 197.15‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - GKOS - Glaukos Corp.
Peers - GKOS - Glaukos Corp.
Peer Comparison
Compared with companies in Medical Devices listed on NYSE.
- GKOSNYSEGlaukos Corp.9.51BMarket Cap+46.05%52-week change-49.20P/E (Trailing)‪-30.68%‬Profit Margin
- CVXNYSEChevron Corporation406.24BMarket Cap+25.86%52-week change19.95P/E (Trailing)‪9.83%‬Profit Margin
- ABTNYSEAbbott Laboratories169.82BMarket Cap-37.17%52-week change31.55P/E (Trailing)‪11.64%‬Profit Margin
- MDTNYSEMedtronic plc110.49BMarket Cap-13.95%52-week change21.28P/E (Trailing)‪13.93%‬Profit Margin
- SYKNYSEStryker Corp.105.64BMarket Cap-32.98%52-week change28.32P/E (Trailing)‪14.43%‬Profit Margin
- ICENYSEIntercontinental Exchange, Inc.84.29BMarket Cap-5.93%52-week change21.39P/E (Trailing)‪38.24%‬Profit Margin
- BSXNYSEBoston Scientific Corp.61.73BMarket Cap-127.00%52-week change17.25P/E (Trailing)‪17.49%‬Profit Margin
Profile Summary - GKOS - Glaukos Corp.
About
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company focused on developing and commercializing novel therapies for glaucoma, corneal disorders, and retinal diseases. Its product portfolio includes Micro-Invasive Glaucoma Surgery (MIGS) devices, sustained-release drug delivery systems, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
